Skip to main content
  • Home
  • Affected by Cancer
  • Healthy living
  • Clinical best practice
  • Research & Data
  • Publications & Resources
  • About us
  • Publications & Resources
  • Publications & Resources
  • Shared follow-up care

More at Cancer Australia

Australian Government - Cancer Australia
Home

CANCER AUSTRALIA STATEMENTS

  • Home
  • Breast cancer
  • Metastatic breast cancer

Practice 9

  • Home
  • Home
  • About the Statement
  • How the Statement was developed
  • The 12 Practices
  • Consumer Fact Sheets
  • mobile menu
  • Home
  • Home
  • About the Statement
  • How the Statement was developed
  • The 12 Practices
  • Consumer Fact Sheets
  • Home
  • Breast cancer
  • Metastatic breast cancer
  • Home
  • Home
  • How the Statement was developed
  • The 10 practices
  • Consumer Fact Sheets
  1. The 12 Practices
  2. Practice 9
  • A|A

Practice 9

Not appropriate to confirm or exclude a diagnosis of breast cancer without undertaking the triple test, which involves:

  • taking a patient history and clinical breast examination;
  • imaging tests (mammogram and/or ultrasound); and
  • biopsy to remove cells or tissue for examination.
Consumer Information
Triple test
investigating
breast symptoms

Investigating a new breast symptom

Download the transcript (DOCX 49.32 KB)

Context

In 2016, it is estimated that there will be 15,930 new cases of breast cancer in Australia.  More than half of these will be diagnosed as a result of the investigation of a breast change.  Studies have shown that the most effective and accurate way to diagnose breast cancer in women with breast symptoms is to use the triple test. 

The triple test refers to three diagnostic components used to investigate new breast symptoms that could be due to breast cancer: (i) patient history and clinical examination; (ii) diagnostic imaging; (iii) non-surgical biopsy.  The correct sequencing of tests and correlation of results with the breast symptom is important to the overall interpretation of the results. 

The triple test is positive if any component is indeterminate, suspicious or malignant.  Any positive result requires further investigation or specialist referral, with the likelihood of cancer increasing if more than one component is positive.  A positive triple test is found in 99.6% of breast cancers.

Value to patients

Providing patients with a confirmed diagnosis of breast cancer is important to enable informed discussions and decision-making around treatment options and to potentially reduce the number of surgical procedures. 

Supporting evidence

National Breast and Ovarian Cancer Centre.  Investigation of a new breast symptom, a guide for general practitioners. 2006 Surry Hills, NSW.

Morris KT, Pommier RF, Morris A, et al. Usefulness of the triple test score for palpable breast masses; discussion 1012-3. Archives of Surgery. 2001 Sep;136(9):1008-12.

Senkus E, Kyriakides S, Ohno S, et al. Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of Oncology. 2015 Sep;26 Suppl 5:v8-30.

published: Sun, 23/10/2016 - 20:33
Previous Next
  • Contact Us
  • Copyright
  • Disclaimer
  • Privacy policy
Copyright © 2021 - Cancer Australia